Summary
- Current Price
- As of today, PVLA price is $163.94, down -2.83% on
- Current Price All-Time High
- PVLA price is currently -78.98% below its historical high of $780.00 set on
- Market Cap
- PVLA current market cap is $2B, up +177.63% over the past 365 days
- Revenue
- PVLA current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for PVLA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Palvella Therapeutics, Inc. |
| Ticker | NASDAQ: PVLA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | palvellatx.com |
| Employees | 14 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $163.94 | |
| Price, 1D Change | -2.83% | |
| $2B | ||
| - | ||
| - | ||
| 1.63 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$3.71 | ||
| EPS, 1Y Change | +52.66% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:80 | |
| Next Split | N/A | N/A |
| Last Ticker Change | PIRS | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$3.71 | ||
| EPS Estimate | -$5.90 | |
| EPS Est. Change | -59.09% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $163.94 | |
| Price Target | $232.00 | - |
| Price Tgt. Change | +41.52% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.01 | -$7.83 | -160.55% | |
| -$3.52 | -$3.71 | -5.44% | |
| -$5.90 | N/A | -59.09% | |
| -$8.19 | N/A | -120.90% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $21.43K | $0.00 | -100.00% | |
| - | $0.00 | - | |
| - | N/A | - | |
| $21.92M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $163.94 | |
| $129.72 | ||
| $143.61 | ||
| $127.28 | ||
| $144.94 | ||
| $8.73 | ||
| 1.63 | ||
| $9.58 | ||
| 61.43 | ||
| 82.32% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$3.71 | ||
| $0.00 | ||
| - | ||
| -$38.60M | ||
| - | ||
| -$41.72M | ||
| - | ||
| -$38.60M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 5.20 | ||
| 5.20 | ||
| - | ||
| - | ||
| 41.18 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 12.11 | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $27.98M | ||
| $57.98M | ||
| $59.56M | ||
| $58.99M | ||
| $31.58M | ||
| $11.34M | ||
| $18.39M | ||
| $202.00K | ||
| $4.60M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $41.72M | ||
| $38.60M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$25.01M | ||
| $0.00 | ||
| -$660.00K | ||
| $0.00 | ||
| -$25.01M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Oppenheimer | → | |
| Chardan Capital | → | |
| William Blair | ||
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| Stephens & Co. | → | |
| Chardan Capital | → | |
| Stephens & Co. | ||
| Chardan Capital | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with PVLA
FAQ
- What is the ticker symbol for Palvella Therapeutics, Inc.?
- The ticker symbol for Palvella Therapeutics, Inc. is NASDAQ:PVLA
- Does Palvella Therapeutics, Inc. pay dividends?
- No, Palvella Therapeutics, Inc. does not pay dividends
- What sector is Palvella Therapeutics, Inc. in?
- Palvella Therapeutics, Inc. is in the Healthcare sector
- What industry is Palvella Therapeutics, Inc. in?
- Palvella Therapeutics, Inc. is in the Biotechnology industry
- What country is Palvella Therapeutics, Inc. based in?
- Palvella Therapeutics, Inc. is headquartered in United States
- When did Palvella Therapeutics, Inc. go public?
- Palvella Therapeutics, Inc. initial public offering (IPO) was on January 2, 2015
- Is Palvella Therapeutics, Inc. in the S&P 500?
- No, Palvella Therapeutics, Inc. is not included in the S&P 500 index
- Is Palvella Therapeutics, Inc. in the NASDAQ 100?
- No, Palvella Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Palvella Therapeutics, Inc. in the Dow Jones?
- No, Palvella Therapeutics, Inc. is not included in the Dow Jones index
- When was Palvella Therapeutics, Inc. last earnings report?
- Palvella Therapeutics, Inc.'s most recent earnings report was on November 5, 2026
- When does Palvella Therapeutics, Inc. report earnings?
- The next expected earnings date for Palvella Therapeutics, Inc. is March 31, 2027
Data Sources & References
- PVLA Official Website palvellatx.com
- PVLA Profile on Yahoo Finance finance.yahoo.com/quote/PVLA
- PVLA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pvla